Who
Kieran Gallahue
Director
Company insider
Files Form 4 as: Director, Envista Holdings; Director, Edwards Lifesciences; Executive Chairman, Intersect ENT; Director, Arena Pharmaceuticals; Chairman and CEO, Carefusion; Director, Volcano; Chief Executive Officer, ResMed.
In numbers
- Trades disclosed
- 336
- Buys
- 3
- Sells
- 45
- Bought
- $625K
- Sold
- $37.8M
- Companies
- 7
- Companies where not an officer
- 4
- First trade
- 3 Feb 2006
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —9,330 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —9,330 at $0.00 | filing |
| 8 May 2026filed 8 May 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,251 at $0.00 | filing |
| 8 May 2026filed 8 May 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —1,064 at $0.00 | filing |
| 8 May 2026filed 8 May 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,251 at $0.00 | filing |
| 8 May 2026filed 8 May 2026 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —1,064 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —10,450 at $0.00 | filing |
| 9 May 2025filed 9 May 2025 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,528 at $0.00 | filing |
| 9 May 2025filed 9 May 2025 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —1,154 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —10,085 at $0.00 | filing |
| 8 May 2024filed 9 May 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —3,055 at $0.00 | filing |
| 8 May 2024filed 9 May 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —999 at $0.00 | filing |
| 23 Feb 2024filed 26 Feb 2024 | EW Edwards Lifesciencesoption or derivative · Medical Devices | SEC FORM 4 Code M | —7,056 at $0.00 | filing |
| 23 Feb 2024filed 26 Feb 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code M | $260K7,056 at $36.86 | filing |
| 23 Feb 2024filed 26 Feb 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code G | —7,056 at $0.00 | filing |
| 23 Feb 2024filed 26 Feb 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code G | —7,056 at $0.00 | filing |
| 23 Feb 2024filed 26 Feb 2024 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Sold | $268K3,058 at $87.61 | filing |
| 23 May 2023filed 25 May 2023 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —5,425 at $0.00 | filing |
| 12 May 2023filed 15 May 2023 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —2,803 at $0.00 | filing |
| 12 May 2023filed 15 May 2023 | EW Edwards LifesciencesMedical Devices | SEC FORM 4 Code A | —898 at $0.00 | filing |
News
Edwards Lifesciences (NYSE:EW) Upgraded to "Buy" at Wall Street ZenEW · dailypolitical.com · 18 Oct 2026Bangkok Post - Edwards Lifesciences Thailand Marks 25 Years in Thailand WITH Access to Heart Valve CareEW · bangkokpost.com · 14 Oct 2026Abbott Laboratories (NYSE:ABT) & ResMed (NYSE:RMD) Head to Head AnalysisRMD · themarketsdaily.com · 8 Oct 2026Edwards Lifesciences (NYSE:EW) Shares Break Above 200-Day Moving Average – What's Next?EW · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Kieran Gallahue; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.